Skip to main content
TipRanks
Go Ultimate75% OFF

Mangalam Drugs & Organics Ltd. (MANGALAM) Stock Statistics & Valuation Metrics

1 Followers

Total Valuation

Mangalam Drugs & Organics Ltd. has a market cap or net worth of INR 468.99M. The enterprise value is INR 1.38B.

Market Cap
INR 468.99M
Enterprise Value
INR 1.38B

Share Statistics

Mangalam Drugs & Organics Ltd. has 15,828,248 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
15,828,248
Owned by Insiders
―
Owned by Institutions
―

Financial Efficiency

Mangalam Drugs & Organics Ltd.’s return on equity (ROE) is -0.43 and return on invested capital (ROIC) is -14.06%.

Return on Equity (ROE)
-0.43
Return on Assets (ROA)
-0.14
Return on Invested Capital (ROIC)
-14.06%
Return on Capital Employed (ROCE)
-0.28
Revenue Per Employee
7.28M
Profits Per Employee
-1.39M
Employee Count
319
Asset Turnover
0.74
Inventory Turnover
2.03

Valuation Ratios

The current PE Ratio of Mangalam Drugs & Organics Ltd. is -1.18. Mangalam Drugs & Organics Ltd.’s PEG ratio is 0.02.

PE Ratio
-1.18
PS Ratio
0.17
PB Ratio
0.51
Price to FCF
0.00
Price to Operating Cash Flow
0.00
PEG Ratio
0.02

Income Statement

In the last 12 months, Mangalam Drugs & Organics Ltd. had revenue of 2.32B and earned -444.00M in profits. Earnings per share was -28.05.

Revenue
2.32B
Gross Profit
232.46M
Operating Income
-331.26M
Pretax Income
-485.71M
Net Income
-444.00M
EBITDA
-149.03M
Earnings Per Share (EPS)
-28.05

Cash Flow

In the last 12 months, operating cash flow was 0 and capital expenditures 0, giving a free cash flow of 0 billion.

Operating Cash Flow
0
Free Cash Flow
0
Free Cash Flow per Share
0.00

Dividends & Yields

Mangalam Drugs & Organics Ltd. pays an annual dividend of INR 0.50, resulting in a dividend yield of ―

Dividend Per Share
INR 0.50
Dividend Yield
―
Payout Ratio
N/A
Free Cash Flow Yield
0.00%
Earnings Yield
-84.79%

Stock Price Statistics

Beta
0.57
52-Week Price Change
-53.11%
50-Day Moving Average
30.91
200-Day Moving Average
29.78
Relative Strength Index (RSI)
49.40
Average Volume (3m)
7,990

Important Dates

Mangalam Drugs & Organics Ltd. upcoming earnings date is Feb 14, 2027, TBA (Not Confirmed).

Last Earnings Date
Nov 05, 2026
Next Earnings Date
Feb 14, 2027
Ex-Dividend Date
Dec 21, 2017

Financial Position

Mangalam Drugs & Organics Ltd. as a current ratio of 0.79, with Debt / Equity ratio of 102.35%

Current Ratio
0.79
Quick Ratio
0.27
Debt to Market Cap
2.37
Net Debt to EBITDA
-7.03
Interest Coverage Ratio
-2.04

Taxes

In the past 12 months, Mangalam Drugs & Organics Ltd. has paid -41.71M in taxes.

Income Tax
-41.71M
Effective Tax Rate
0.09

Enterprise Valuation

Mangalam Drugs & Organics Ltd. EV to EBITDA ratio is -18.94, with an EV/FCF ratio of 0.00.

EV to Sales
0.51
EV to EBITDA
-18.94
EV to Free Cash Flow
0.00
EV to Operating Cash Flow
0.00

Balance Sheet

Mangalam Drugs & Organics Ltd. has INR 8.35M in cash and marketable securities with INR 903.89M in debt, giving a net cash position of -INR 895.54M billion.

Cash & Marketable Securities
INR 8.35M
Total Debt
INR 903.89M
Net Cash
-INR 895.54M
Net Cash Per Share
-INR 56.58
Tangible Book Value Per Share
INR 35.21

Margins

Gross margin is 6.41%, with operating margin of -9.39%, and net profit margin of -14.53%.

Gross Margin
6.41%
Operating Margin
-9.39%
Pretax Margin
-14.81%
Net Profit Margin
-14.53%
EBITDA Margin
-2.71%
EBIT Margin
-9.31%

Analyst Forecast

The average price target for Mangalam Drugs & Organics Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target
―
Price Target Upside
―
Analyst Consensus
―
Analyst Count
―
Revenue Growth Forecast
-2.37%
EPS Growth Forecast
-92.45%

Scores

Smart Score
―
AI Score
50